{
    "id": "MISSION-500-141-1771350858744",
    "questionType": "orderedResponse",
    "question": "The nurse in the Emergency Department is caring for a client diagnosed with an acute ischemic stroke. The stroke team has determined the client is a candidate for alteplase (tPA). Drag the actions the nurse should perform in order from first to last.",
    "tabs": [
        {
            "label": "Nurses' Notes",
            "content": {
                "type": "note",
                "author": "RN",
                "timestamp": "13:15",
                "text": "Client is a 68-year-old male who arrived via ambulance with acute onset of right-sided facial droop, right arm weakness, and expressive aphasia. Symptoms began at 12:00, per client's spouse. Client's spouse reports a history of hypertension and type 2 diabetes. States client has 'not been himself' for a few weeks and was recently in another hospital for 'low blood counts' and has been bruising very easily. Client is a seasonal farmworker with infrequent access to a primary care provider. NIH Stroke Scale (NIHSS) score is 14. Non-contrast head CT completed."
            }
        },
        {
            "label": "Vital Signs",
            "content": {
                "type": "trend",
                "headers": [
                    "Time",
                    "BP (mmHg)",
                    "HR (bpm)",
                    "RR (breaths/min)",
                    "SpO2 (%)"
                ],
                "rows": [
                    [
                        "13:10 (Arrival)",
                        "195/110",
                        "98",
                        "18",
                        "96% RA"
                    ],
                    [
                        "13:25 (Post Labetalol 10mg IV)",
                        "182/104",
                        "92",
                        "18",
                        "97% RA"
                    ]
                ]
            }
        },
        {
            "label": "Laboratory Results",
            "content": {
                "type": "labs",
                "groups": [
                    {
                        "name": "Complete Blood Count (CBC)",
                        "values": [
                            {
                                "name": "WBC",
                                "value": "8.2",
                                "unit": "x 10³/μL",
                                "range": "4.5-11.0"
                            },
                            {
                                "name": "Hgb",
                                "value": "10.1",
                                "unit": "g/dL",
                                "range": "13.5-17.5"
                            },
                            {
                                "name": "Platelets",
                                "value": "45",
                                "unit": "x 10³/μL",
                                "range": "150-400",
                                "isCritical": true
                            },
                            {
                                "name": "Hct",
                                "value": "31%",
                                "unit": "%",
                                "range": "41-53"
                            }
                        ]
                    },
                    {
                        "name": "Coagulation Panel",
                        "values": [
                            {
                                "name": "PT",
                                "value": "12.8",
                                "unit": "sec",
                                "range": "11-13.5"
                            },
                            {
                                "name": "INR",
                                "value": "1.0",
                                "unit": null,
                                "range": "0.8-1.1"
                            }
                        ]
                    },
                    {
                        "name": "Basic Metabolic Panel (BMP)",
                        "values": [
                            {
                                "name": "Glucose",
                                "value": "225",
                                "unit": "mg/dL",
                                "range": "70-110",
                                "isCritical": true
                            },
                            {
                                "name": "Creatinine",
                                "value": "1.4",
                                "unit": "mg/dL",
                                "range": "0.7-1.3"
                            }
                        ]
                    }
                ]
            }
        },
        {
            "label": "Diagnostic Results",
            "content": {
                "type": "report",
                "title": "Non-Contrast Head CT",
                "timestamp": "13:20",
                "body": "FINDINGS: No evidence of acute intracranial hemorrhage, mass effect, or hydrocephalus. Subtle loss of gray-white differentiation in the left MCA territory suggesting early ischemic changes.\n\nIMPRESSION: No acute hemorrhage. Findings suspicious for acute left MCA territory ischemic stroke."
            }
        }
    ],
    "options": [
        {
            "id": "opt_1",
            "label": "Administer a second dose of IV labetalol to lower blood pressure."
        },
        {
            "id": "opt_3",
            "label": "Establish a second large-bore peripheral IV line."
        },
        {
            "id": "opt_5",
            "label": "Inform the client's spouse that alteplase is contraindicated."
        },
        {
            "id": "opt_4",
            "label": "Confirm the client's weight to calculate the alteplase dose."
        },
        {
            "id": "opt_2",
            "label": "Immediately notify the healthcare provider of the platelet count."
        }
    ],
    "correctResponse": [
        "opt_2",
        "opt_5",
        "opt_1",
        "opt_4",
        "opt_3"
    ],
    "scoring": {
        "type": "orderedResponse"
    },
    "answerBreakdown": [
        {
            "optionId": "opt_2",
            "rationale": "This is the first and most critical action. A platelet count less than 100,000/μL is an absolute contraindication for alteplase administration due to the profound risk of catastrophic intracerebral hemorrhage. The nurse has identified a 'killer' lab value that creates a 'safety stop' moment. All other actions must be halted, and the provider must be notified immediately to prevent a life-threatening medication error."
        },
        {
            "optionId": "opt_5",
            "rationale": "After notifying the provider and receiving confirmation that alteplase will be withheld, the next priority is to communicate this change in the plan of care to the family. This manages expectations and allows for discussion of alternative treatments. Communicating with the family is a crucial step after a definitive clinical decision has been made."
        },
        {
            "optionId": "opt_1",
            "rationale": "While the client's blood pressure of 182/104 mmHg is still above the target of <185/110 mmHg for alteplase administration, managing the blood pressure is no longer for the purpose of giving tPA. It becomes part of the general management of acute ischemic stroke. This action is necessary but is a lower priority than identifying the contraindication and communicating the change in plan."
        },
        {
            "optionId": "opt_4",
            "rationale": "This action is now irrelevant and a low priority. Since the client is not a candidate for alteplase due to severe thrombocytopenia, calculating the dose is an unnecessary step. Performing this action before addressing the critical lab value would demonstrate a failure to recognize a life-threatening contraindication."
        },
        {
            "optionId": "opt_3",
            "rationale": "This is the lowest priority action. Establishing a second IV line is a preparatory step for administering alteplase and other supportive medications. As alteplase is contraindicated, the urgency of this task is significantly reduced. The client's immediate safety is not dependent on this action."
        }
    ]
}